Feeds › Clinical trial updates
Clinical trial updates
Drug and device trials that companies register on ClinicalTrials.gov: newly completed phase 3 studies, changes of status and the dates a study is due to finish.
About this data
- What it is
- ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
- Who files it
- The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
- How current
- We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
- Terms
- ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
- Worth knowing
- A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
- Not to be confused with
- FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.
All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.
Source and freshness · Information, not investment advice (disclaimer).
Studies updated per day, last 30 days
All industry-sponsored studies Sponsor matched to a public company
By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.
Latest clinical trial updates
Showing: ticker PG · All recent updates
Studies by the date their record was last updated.
| Updated | Study | SponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private. | PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages. | StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time). | Enrolled | Primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update. | Source |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control. NCT06892834 · Gingivitis Stannous Fluoride Dentifrice, Sodium Fluoride Dentifrice | PG Procter and Gamble | Phase 2 | Completed | 120 | Jun 19, 2025 | Registry ↗ |
| Oct 7, 2025 | A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods NCT07211061 · Gingivitis Stannous Fluoride Dentifrice, Sodium Fluoride Dentifrice | PG Procter and Gamble | Phase 4 | Completed | 69 | Nov 10, 2011 | Registry ↗ |
| Sep 23, 2025 | Assessing Gingivitis and Plaque From a Marketed Toothpaste NCT07158112 · Gingivitis Stannous Fluoride Dentifrice, Test Stannous Fluoride Dentif… | PG Procter and Gamble | Phase 4 | Active, not recruiting | 120 | Dec 7, 2025 | Registry ↗ |
| Jun 3, 2025 | Evaluating Gingivitis and Systemic Biomarkers NCT06962956 · Gingivitis 0.76% Sodium Monofluorophosphate Dentifrice, 0.454% Stannou… | PG Procter and Gamble | Phase 1 | Active, not recruiting | 135 | Oct 31, 2025 | Registry ↗ |
| Dec 16, 2024 | Salivary Fluoride Clearance NCT06735235 · Caries 0 ppm F, 250 ppm F as MFP | PG Procter and Gamble | Phase 1 | Completed | 27 | Jul 29, 2021 | Registry ↗ |
| Oct 26, 2024 | Brief Title: a Clinical Study to Assess Gingivitis NCT06659471 · Gingival Diseases 0.76% Sodium Monofluorophosphate Dentifrice, 0.454% Stannou… | PG Procter and Gamble | Not applicable | Completed | 120 | Jun 6, 2022 | Registry ↗ |
| Oct 1, 2024 | Overnight Pant Study for Children With Nocturnal Enuresis NCT05178641 · Nocturnal Enuresis Ninjamas Pyjama Pants, Participant's Overnight Current Stan… | PG Procter and Gamble | Not applicable | Completed | 32 | Feb 28, 2022 | Registry ↗ |
| Mar 1, 2024 | A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices NCT06140784 · Gingivitis 0.76% Sodium Monofluorophosphate Dentifrice, 0.454% Stannou… | PG Procter and Gamble | Not applicable | Completed | 116 | Dec 10, 2023 | Registry ↗ |
| Feb 29, 2024 | Evaluation of the Anticaries Efficacy of Dentifrice Formulations Using an In-situ Model NCT06140758 · Caries Oral-B 1450 ppm Fluoride (1.16% sodium monofluorophosphate)… | PG Procter and Gamble | Not applicable | Completed | 12 | Dec 11, 2023 | Registry ↗ |
| Nov 28, 2023 | A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clini… NCT05619328 · Peripheral Sensory Neuropathy of Different Etiologies Vitamin B combination tablet, Placebo Tablet | PG Procter and Gamble | Phase 3 | Completed | 323 | Nov 2, 2023 | Registry ↗ |
| Nov 20, 2023 | A Clinical Study to Assess the Gingivitis Effects of Various Dentifrices NCT06140771 · Gingivitis 0.76% Sodium Monofluorophosphate Dentifrice, 1.15% Sodium M… | PG Procter and Gamble | Not applicable | Completed | 115 | Feb 6, 2022 | Registry ↗ |
| Nov 20, 2023 | Evaluation of Dentifrice Formulations to Remineralize Enamel and Dentine Subsurface Lesions in a Do… NCT06140745 · Caries 0 ppm Fluoride Dentifrice 1, 1100 ppm NaF Fluoride Dentifri… | PG Procter and Gamble | Not applicable | Completed | 10 | Feb 21, 2021 | Registry ↗ |
| Nov 18, 2023 | Meta-analysis of Stannous Fluoride and the Effects on Dental Plaque NCT04006483 · Dental Plaque Stannous fluoride dentifrice, Positive control dentifrice | PG Procter and Gamble | — | Completed | 2,359 | Nov 30, 2018 | Registry ↗ |
| Nov 18, 2023 | Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) NCT00091637 · Acute Myocardial Infarction Pexelizumab, Placebo infusion | PG Procter and Gamble | Phase 3 | Completed | 5,745 | May 2007 | Registry ↗ |
| Nov 15, 2023 | A Study to Evaluate Sampling Methods for Subgingival Plaque NCT02841839 · Subgingival Plaque Stannous Fluoride | PG Procter and Gamble | Not applicable | Completed | 20 | Jun 2016 | Registry ↗ |
| Jun 23, 2023 | A Three Month Bleeding-Model Clinical Study NCT05916521 · Gingivitis 0.454% stannous fluoride, 0.76% sodium monofluorophosphate | PG Procter and Gamble | Not applicable | Completed | 90 | Feb 11, 2022 | Registry ↗ |
| Jun 23, 2023 | A Bleeding-Model Clinical Study NCT05916508 · Gingivitis 0.454% stannous fluoride, 0.76% sodium monofluorophosphate | PG Procter and Gamble | Not applicable | Completed | 90 | Nov 20, 2020 | Registry ↗ |
| Jun 18, 2023 | A Study to Determine the Efficacy of a Denture Adhesive to Seal Out Food Particles From Under the M… NCT05908890 · Partial Denture Experimental Denture Adhesive, Fixodent True Feel Denture A… | PG Procter and Gamble | Not applicable | Completed | 29 | Oct 3, 2019 | Registry ↗ |
| Jun 8, 2023 | A Clinical Study to Assess the Plaque and Gingivitis Effects of a Stannous Fluoride Dentifrice NCT03936569 · Gingivitis Marketed Toothpaste, Marketed Cavity Protection Toothpaste | PG Procter and Gamble | Phase 4 | Completed | 90 | Jan 25, 2019 | Registry ↗ |
| Apr 21, 2023 | Oral Hygiene and Maternity Outcomes Multicenter Study (OHMOM) NCT01549587 · Gingivitis, Pregnancy 0.243% sodium fluoride, toothbrush | PG Procter and Gamble | Not applicable | Completed | 746 | Feb 2014 | Registry ↗ |
| Oct 26, 2022 | A Meta-analysis Comparing Toothbrushes on Plaque Removal and Gingival Health NCT05594004 · Gingivitis, Dental Plaque Oscillating-rotating electric toothbrush, Sonic electric to… | PG Procter and Gamble | — | Completed | 2,929 | Jul 29, 2022 | Registry ↗ |
| Aug 1, 2022 | Measuring Efficacy of an Oral-Irrigator After Three Weeks of Use NCT04899440 · Gingivitis, Plaque Water Flosser, Control | PG Procter and Gamble | — | Completed | 30 | Jun 24, 2021 | Registry ↗ |
| Jul 19, 2022 | Evaluation of the Fluoride Dose Response Using In Situ Caries Model NCT04763044 · Caries 0 ppm F, 250 ppm F as MFP | PG Procter and Gamble | Phase 4 | Completed | 15 | Jul 21, 2021 | Registry ↗ |
| Jun 28, 2022 | Assessing Effects of a Denture Gel on Gum Abrasions NCT04913636 · Gum Injury Treatment Gel, Sham Control | PG Procter and Gamble | Not applicable | Completed | 38 | Jun 29, 2021 | Registry ↗ |
| Jun 16, 2022 | Stannous Fluoride and Gingivitis NCT05326373 · Gingivitis Stannous fluoride | PG Procter and Gamble | Not applicable | Completed | 40 | Jun 13, 2022 | Registry ↗ |
| Jun 9, 2022 | In-use Cross-over Study of Two Different Menstrual Cups NCT05411796 · Menstruation Tampax menstrual cup, Other menstrual cup | PG Procter and Gamble | Not applicable | Completed | 65 | Nov 14, 2018 | Registry ↗ |
| May 28, 2021 | Improvement of Dry Mouth Sufferers After Using an Experimental Dry Mouth Rinse Compared to a Water… NCT04189081 · Dry Mouth dry mouth rinse, Water Control | PG Procter and Gamble | Not applicable | Completed | 137 | Jul 8, 2020 | Registry ↗ |
| Feb 2, 2021 | A Pilot Study to Assess Dry Mouth Relief After Using an Experimental Mouth Rinse NCT04152642 · Dry Mouth Marketed Dry Mouth Rinse, Water control | PG Procter and Gamble | Not applicable | Completed | 22 | Dec 5, 2019 | Registry ↗ |
| Dec 17, 2020 | 8-Week Atopic Dermatitis (AD) Treatment Study NCT03386032 · Atopic Dermatitis Eczema Investigational OTC Cream, 0.05% Desonide | PG Procter and Gamble | Phase 3 | Completed | 65 | Aug 18, 2018 | Registry ↗ |
| Oct 30, 2020 | A Clinical Study to Assess the Effects of Various Dentifrice Technologies on Dentinal Hypersensitiv… NCT03965039 · Dentin Hypersensitivity Dipotassium oxalate toothpaste, Stannous fluoride toothpaste | PG Procter and Gamble | Not applicable | Completed | 120 | Oct 3, 2019 | Registry ↗ |
| Sep 22, 2020 | Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental P… NCT02613117 · Dentinal Hypersensitivity Potassium Oxalate Gel, Potassium Oxalate Liquid | PG Procter and Gamble | Not applicable | Completed | 104 | Jun 2016 | Registry ↗ |
| Sep 18, 2020 | Effectiveness of Two Water-Based Potassium Oxalate Desensitizers on Dental Hypersensitivity NCT02152826 · Dentin Sensitivity Potassium oxalate | PG Procter and Gamble | Not applicable | Completed | 80 | Sep 2014 | Registry ↗ |
| Sep 9, 2020 | A Clinical Study of Two Dentinal Hypersensitivity Treatments Used With Normal Oral Hygiene NCT02221349 · Dentin Sensitivity Potassium oxalate, Sodium fluoride paste | PG Procter and Gamble | Not applicable | Completed | 30 | Oct 2014 | Registry ↗ |
| Aug 31, 2020 | A Clinical Study to Determine the Safety and Effectiveness of Dentinal Hypersensitivity Treatment W… NCT02513212 · Dentin Sensitivity Potassium Oxalate, Stannous fluoride paste | PG Procter and Gamble | Not applicable | Completed | 24 | Sep 2015 | Registry ↗ |
| Dec 4, 2019 | A Clinical Study to Assess the Effects of a Stannous Fluoride Dentifrice on Plaque and Gingivitis NCT03936556 · Gingivitis Marketed toothpaste, Marketed Cavity Protection Toothpaste | PG Procter and Gamble | Phase 4 | Completed | 84 | Jun 3, 2018 | Registry ↗ |
| Nov 5, 2019 | Effectiveness of Two Water-Based Potassium Oxalate Desensitizers NCT02192307 · Dentin Sensitivity Potassium oxalate | PG Procter and Gamble | Not applicable | Completed | 60 | Sep 2014 | Registry ↗ |
| Sep 4, 2019 | Evaluate Dental Plaque Benefit of a Preventive Treatment Gel NCT03546491 · Dental Plaque Preventive Gel, Marketed Control | PG Procter and Gamble | Phase 3 | Completed | 32 | Jun 22, 2018 | Registry ↗ |
| Aug 28, 2019 | A Pilot Study to Assess Nominal Versus Controlled Stimuli on Dentinal Hypersensitivity NCT02406573 · Dentin Sensitivity Crest® Sensi-Stop™ Strips | PG Procter and Gamble | Not applicable | Completed | 30 | Apr 2015 | Registry ↗ |
| Aug 26, 2019 | In-use Study of Four Different Tampons NCT03478371 · Menstruation tampon D, tampon M | PG Procter and Gamble | Not applicable | Completed | 94 | Jul 18, 2018 | Registry ↗ |
| Aug 15, 2019 | The Effects of Oscillating-Rotating Electric Toothbrushes on Plaque and Gingival Health NCT04017507 · Gingivitis, Plaque Oscillating-rotating electric toothbrush, Side-to-side elec… | PG Procter and Gamble | — | Completed | 2,145 | Nov 30, 2018 | Registry ↗ |
| Jul 5, 2019 | Meta-analysis of Stannous Fluoride and the Effects on Enamel Erosion NCT04006470 · Enamel Erosion Stannous fluoride dentifrice, Positive control dentifrice | PG Procter and Gamble | — | Completed | 172 | Nov 30, 2018 | Registry ↗ |
| Jul 2, 2019 | Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity NCT04005417 · Dentine Hypersensitivity Stannous fluoride dentifrice, Positive control dentifrice | PG Procter and Gamble | — | Completed | 1,036 | Nov 30, 2018 | Registry ↗ |
| Jun 25, 2019 | A Pilot Clinical Study to Evaluate the Safety and Efficacy of Marketed Oxalate Strips Compared to a… NCT02384044 · Dentin Sensitivity Crest® Sensi-Stop™ Strips, Colgate® Sensitivity Relief Pen | PG Procter and Gamble | Not applicable | Completed | 30 | Mar 2015 | Registry ↗ |
| Jun 25, 2019 | A Study to Evaluate the Safety and Efficacy of an Oxalate Strip on Adjacent Teeth With Dentinal Hyp… NCT02293044 · Dentin Sensitivity Crest® Sensi-Stop™ Strips | PG Procter and Gamble | Not applicable | Completed | 15 | Nov 2014 | Registry ↗ |
| Jun 17, 2019 | Meta-analysis of Stannous Fluoride and the Effects on Gingival Health NCT03970759 · Gingivitis Stannous Fluoride Dentifrice, Positive control dentifrice | PG Procter and Gamble | — | Completed | 2,890 | Nov 30, 2018 | Registry ↗ |
| Jun 17, 2019 | A Clinical Study to Compare Professional Treatments for Dentinal Hypersensitivity NCT03405259 · Dentinal Hypersensitivity Super Seal® Desensitizer, Acclean® Fluoride Varnish | PG Procter and Gamble | Not applicable | Completed | 22 | Sep 13, 2013 | Registry ↗ |
| Jun 11, 2019 | Effects of an Oxalate Containing Product on Dentinal Hypersensitivity With Dental Prophylaxis NCT02481557 · Dentin Sensitivity Oxalate Salt Solution | PG Procter and Gamble | Not applicable | Completed | 36 | Jun 2015 | Registry ↗ |
| Apr 2, 2019 | Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2 NCT00780286 · Healthy Subjects Polymer based lubricating liquid, Moi-Stir | PG Procter and Gamble | Phase 1 | Completed | 32 | Oct 2008 | Registry ↗ |
| Mar 26, 2019 | Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy NCT00754091 · Healthy Subjects Polymer based lubricating liquid | PG Procter and Gamble | Phase 1 | Completed | 16 | Jun 2008 | Registry ↗ |
| Sep 27, 2018 | A Clinical Comparison of an Experimental Power Brush Compared to a Manual Toothbrush NCT03624647 · Gingivitis, Dental Plaque Power toothbrush, Manual toothbrush | PG Procter and Gamble | Not applicable | Completed | 110 | Sep 14, 2018 | Registry ↗ |
The newest 50 items, most recent first. Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 7:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances